{"id":17632,"date":"2024-07-28T17:42:44","date_gmt":"2024-07-28T16:42:44","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=17632"},"modified":"2024-10-05T15:12:29","modified_gmt":"2024-10-05T14:12:29","slug":"marijuana-rescheduling-nprm-508-comment","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2024\/07\/marijuana-rescheduling-nprm-508-comment\/","title":{"rendered":"Marijuana Rescheduling &#8211; NPRM 508 &#8211; Comment"},"content":{"rendered":"<p>SUMMARY: The Department of Justice (\u201cDOJ\u201d) proposes to transfer marijuana from schedule<br \/>\nI of the Controlled Substances Act (\u201cCSA\u201d) to schedule III of the CSA, consistent with the view<br \/>\nof the Department of Health and Human Services (\u201cHHS\u201d) that marijuana has a currently<br \/>\naccepted medical use as well as HHS\u2019s views about marijuana\u2019s abuse potential and level of<br \/>\nphysical or psychological dependence. The CSA requires that such actions be made through<br \/>\nformal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is<br \/>\nfinalized, the regulatory controls applicable to schedule III controlled substances would apply, as<br \/>\nappropriate, along with existing marijuana-specific requirements and any additional controls that<br \/>\nmight be implemented, including those that might be implemented to meet U.S. treaty<br \/>\nobligations. If marijuana is transferred into schedule III, the manufacture, distribution,<br \/>\ndispensing, and possession of marijuana would remain subject to the applicable criminal<br \/>\nprohibitions of the CSA. Any drugs containing a substance within the CSA\u2019s definition of<br \/>\n\u201cmarijuana\u201d would also remain subject to the applicable prohibitions in the Federal Food, Drug,<br \/>\nand Cosmetic Act (\u201cFDCA\u201d). DOJ is soliciting comments on this proposal.<\/p>\n<p>NDPA EXPLANATORY: GUIDANCE TO THE ATTORNEY GENERAL&#8217;S COMMENT:<\/p>\n<p>To access the Attorney General&#8217;s full document:<\/p>\n<ol>\n<li>Click on the link below.<\/li>\n<li>An image\u00a0 &#8211; the front page of the full document will appear.<\/li>\n<li><span style=\"text-decoration: underline;\"><em>This image will be somewhat blurred &#8211; C<\/em><\/span><span style=\"text-decoration: underline;\"><em>LICKING ON IT WILL STILL ACTIVATE IT.<\/em><\/span><\/li>\n<li>Click on the image to open the full document.<\/li>\n<\/ol>\n<p><a href=\"https:\/\/drugprevent.org.uk\/ppp\/2024\/07\/marijuana-rescheduling-nprm-508-comment\/scheduling-nprm-508\/\" rel=\"attachment wp-att-17633\">Scheduling NPRM 508<\/a><\/p>\n<p>Source:<\/p>\n<p>21 CFR Part 1308 &#8211; Docket No. DEA-1362; A.G. Order No. 5931-2024 &#8211; DEA USA.<br \/>\n&#8216;Schedules of Controlled Substances: Rescheduling of Marijuana&#8217;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SUMMARY: The Department of Justice (\u201cDOJ\u201d) proposes to transfer marijuana from schedule I of the Controlled Substances Act (\u201cCSA\u201d) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (\u201cHHS\u201d) that marijuana has a currently accepted medical use as well as HHS\u2019s views about marijuana\u2019s abuse potential [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30,104,14,19],"tags":[],"class_list":["post-17632","post","type-post","status-publish","format-standard","hentry","category-cannabis-marijuana","category-political-sector","category-social-affairs","category-usa"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/17632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=17632"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/17632\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=17632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=17632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=17632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}